STOCKHOLDERS' DEFICIENCY (Details Textual)

v2.4.0.6

STOCKHOLDERS' DEFICIENCY (Details Textual) (USD $)	1 Months Ended	3 Months Ended							6 Months Ended		12 Months Ended									3 Months Ended			6 Months Ended	3 Months Ended	6 Months Ended			6 Months Ended	12 Months Ended			6 Months Ended		12 Months Ended		12 Months Ended		12 Months Ended				6 Months Ended	12 Months Ended		3 Months Ended		6 Months Ended			3 Months Ended		6 Months Ended			12 Months Ended		12 Months Ended			12 Months Ended						12 Months Ended			12 Months Ended	6 Months Ended		6 Months Ended						1 Months Ended		6 Months Ended											6 Months Ended											6 Months Ended		12 Months Ended		12 Months Ended
	Mar. 31, 2010	Mar. 31, 2013	Mar. 26, 2013	Mar. 31, 2013	Dec. 31, 2012	Feb. 29, 2012	Mar. 31, 2011	Jan. 14, 2013	Mar. 31, 2013	Mar. 31, 2012	Dec. 31, 2010	Sep. 30, 2010	Sep. 30, 2006	Sep. 30, 2012	Apr. 02, 2012	Mar. 22, 2012	Sep. 30, 2011	Apr. 30, 2011	Aug. 03, 2006	Mar. 31, 2013 October 2012 Notes [Member]	Nov. 30, 2012 October 2012 Notes [Member]	Sep. 30, 2012 October 2012 Notes [Member]	Mar. 31, 2013 Private Placement [Member]	Dec. 31, 2012 Forfeiture and Exchange Agreements [Member]	Mar. 31, 2013 Forfeiture and Exchange Agreements [Member]	Mar. 31, 2013 Plan 2012 [Member]	Dec. 31, 2012 Plan 2012 [Member]	Mar. 31, 2013 Plan 2006 [Member]	Sep. 30, 2011 Plan 2006 [Member]	Jun. 03, 2011 Plan 2006 [Member]	Mar. 03, 2010 Plan 2006 [Member]	Mar. 31, 2013 Amendment Plan 2012 [Member]	Mar. 31, 2012 Unsecured Convertible Notes Payable [Member]	Sep. 30, 2012 Unsecured Convertible Notes Payable [Member]	Mar. 31, 2013 Unsecured Convertible Notes Payable [Member]	Sep. 30, 2012 Warrant One [Member]	Sep. 30, 2011 Warrant One [Member]	Sep. 30, 2012 Warrant Two [Member]	Sep. 30, 2012 Warrant Three [Member]	Sep. 30, 2012 Warrant Four [Member]	Sep. 30, 2012 Warrant Five [Member]	Mar. 31, 2013 Common Stock [Member]	Sep. 30, 2012 Common Stock [Member]	Mar. 31, 2013 New Series Of Preferred Stock [Member]	Mar. 26, 2013 Minimum [Member]	Jan. 14, 2013 Minimum [Member]	Mar. 31, 2013 Minimum [Member]	Mar. 31, 2012 Minimum [Member]	Mar. 31, 2013 Minimum [Member] Plan 2012 [Member]	Mar. 26, 2013 Maximum [Member]	Jan. 14, 2013 Maximum [Member]	Mar. 31, 2013 Maximum [Member]	Mar. 31, 2013 Maximum [Member] Plan 2012 [Member]	Mar. 31, 2013 John Pappajohn [Member] October 2012 Notes [Member]	Sep. 30, 2012 John Pappajohn [Member] Warrant Three [Member]	Mar. 31, 2013 Investor One [Member] Warrant One [Member]	Sep. 30, 2012 Investor One [Member] Warrant Three [Member]	Sep. 30, 2012 Zanett Opportunity Fund Issue One [Member] Warrant Three [Member]	Mar. 31, 2012 Investor Two [Member] Warrant Two [Member]	Sep. 30, 2012 Investor Two [Member] Warrant Three [Member]	Sep. 30, 2012 Zanett Opportunity Fund Issue Two [Member] Warrant Three [Member]	Sep. 30, 2012 Zanett Opportunity Fund Issue Three [Member] Warrant Three [Member]	Sep. 30, 2012 Investors Three [Member] Warrant Three [Member]	Sep. 30, 2010 Monarch Capital Group Llc [Member] October 2012 Notes [Member]	Mar. 31, 2013 Monarch Capital Group Llc [Member] Warrant One [Member]	Sep. 30, 2012 Monarch Capital Group Llc [Member] Warrant Four [Member]	Mar. 31, 2013 Monarch Capital Group Llc [Member] Minimum [Member]	Mar. 31, 2013 Monarch Capital Group Llc [Member] Maximum [Member]	Sep. 30, 2012 Innerkip Capital Management [Member] Warrant Four [Member]	Mar. 31, 2013 Mr. Tony Pullen [Member] October 2012 Notes [Member]	Mar. 31, 2013 Mr. Tony Pullen [Member] Warrant Two [Member]	Mar. 31, 2013 Sail Venture Partners [Member] Warrant Three [Member] Secured Convertible Subordinated Notes Payable [Member]	Mar. 31, 2013 Accredited Third Party Investor [Member] October 2012 Notes [Member]	Mar. 31, 2013 Accredited Third Party Investor [Member] Private Placement [Member]	Mar. 31, 2013 Investor [Member] Warrant Three [Member]	Mar. 31, 2012 Investor [Member] Warrant Three [Member]	Nov. 28, 2012 Andy Sassine [Member] October 2012 Notes [Member]	Mar. 31, 2011 Management [Member]	Mar. 31, 2010 Management [Member]	Mar. 31, 2013 Accredited Investors [Member] Private Placement [Member]	Mar. 31, 2013 Two Affiliates [Member] Private Placement [Member]	Mar. 31, 2013 Tierney Family Trust [Member]	Mar. 31, 2013 Tierney Family Trust [Member] October 2012 Notes [Member]	Mar. 31, 2013 Paul Buck [Member]	Mar. 31, 2013 Paul Buck [Member] Forfeiture and Exchange Agreements [Member]	Mar. 31, 2013 Paul Buck [Member] Plan 2012 [Member]	Mar. 31, 2013 Key Consultants [Member]	Mar. 31, 2012 Director [Member] Warrant One [Member]	Mar. 22, 2012 Director One [Member]	Mar. 22, 2012 Director Two [Member]	Mar. 31, 2013 George Carpenter [Member] Forfeiture and Exchange Agreements [Member]	Mar. 31, 2013 George Carpenter [Member] Plan 2012 [Member]	Mar. 31, 2013 Michael Darkoch [Member] Forfeiture and Exchange Agreements [Member]	Mar. 31, 2013 Michael Darkoch [Member] Plan 2012 [Member]	Mar. 31, 2012 Michael Darkoch [Member] Plan 2012 [Member]	Mar. 31, 2013 Three Existing and Four New Board [Member] Plan 2012 [Member]	Mar. 31, 2013 Five Former Directors [Member] Plan 2012 [Member]	Mar. 31, 2013 Staff [Member]	Mar. 31, 2012 CNS California [Member]	Mar. 31, 2013 CNS California [Member]	Mar. 31, 2013 Colorado CNS Response [Member]	Mar. 31, 2013 Neuro-Therapy Clinic Inc [Member]	Mar. 31, 2013 Affiliated Entity [Member] Warrant One [Member]	Sep. 30, 2010 Affiliated Entity [Member] Warrant One [Member] Unsecured Convertible Notes Payable [Member]	Dec. 31, 2012 Affiliated Entity [Member] Warrant One [Member] Unsecured Convertible Notes Payable [Member]	Dec. 31, 2011 Affiliated Entity [Member] Warrant Three [Member]
Common stock, shares authorized (in shares)		100,000,000		100,000,000					100,000,000					100,000,000																																																																																						80,000,000	1,000,000	10,000
Common Stock Shares Authorized Increased Number		150,000,000		150,000,000					150,000,000
Common stock, par value (in dollars per share)		$ 0.001		$ 0.001					$ 0.001					$ 0.001																																																																		$ 0.001
Common stock, shares issued (in shares)		29,817,468		29,817,468					29,817,468					1,914,175
Common stock, shares outstanding (in shares)		29,817,468		29,817,468					29,817,468					1,914,175
Preferred Stock, Shares Authorized																																												15,000,000																																																								20,000,000
Common Stock, Capital Shares Reserved for Future Issuance	666,667														750,000,000	333,334			333,334												333,334
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee	133,333												100,000
Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Description and Terms									The option price for each share of stock subject to an option shall be (i) no less than the fair market value of a share of stock on the date the option is granted, if the option is an ISO, or (ii) no less than 85% of the fair market value of the stock on the date the option is granted, if the option is a NSO; provided, however, if the option is an ISO granted to an eligible employee who is a 10% shareholder, the option price for each share of stock subject to such ISO shall be no less than 110% of the fair market value of a share of stock on the date such ISO is granted. Stock options have a maximum term of ten years from the date of grant, except for ISOs granted to an eligible employee who is a 10% shareholder, in which case the maximum term is five years from the date of grant. ISOs may be granted only to eligible employees.
Debt Conversion, Converted Instrument, Warrants or Options Issued									713,631																											613,782		31,112	696,673	5,334	15,167														250,002		26,667	83,334		60,001	13,334	30,000	233,335									520,666																														30,000				83,334
Notes Payable, Related Parties		$ 80,000		$ 80,000					$ 80,000	$ 80,000								$ 50,000								$ 350,000	$ 650,000																													$ 60,000			$ 250,000							$ 80,000			$ 650,000						$ 80,000													$ 80,000															$ 40,000		$ 90,000
Number of Shares, Granted				3,810,000	5,395,000																					9,247,670						250,000																																														15,834	288,334								1,600,000											1,960,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value							$ 14.10
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number																42,670														439,689																																																											8,334	8,334
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Exercise Price																$ 3
Number of Shares, Exercised				0	0																							70,825
Number of Shares, Outstanding at December 31, 2011		9,749,594		9,749,594	5,939,594				9,749,594					546,746														501,924																									28,648
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number		6,132		6,132					6,132
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit																													$ 3.60
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit																													$ 32.70
Warrants Outstanding Exercise Price																																															$ 0.04718					$ 9.90
Warrants Outstanding Weighted Average Exercise Price		$ 3.73		$ 3.73					$ 3.73
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized		4,687,600		4,687,600					4,687,600
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant																										5,752,330		87,786
Conversion of promissory note									2,578,000																																	25,000
Conversion of promissory note (in shares)																																										24,957,503
Debt Conversion, Original Debt, Amount		2,327,300																		1,077,300																							50,000																																								200,000
Debt Instrument, Face Amount		7,284,800		7,284,800					7,284,800												1,600,000	1,998,100													90,000		2,000,000		2,000,000															500,000	750,000		80,000	250,000		180,000	40,000	90,000	700,000	60,000	60,000						350,000					750,000	25,000						200,000
Employee Compensation Terms Of Waiver					Pursuant to these agreements, the executives agreed to waive receipt of and release the Company from the payment of 50% of their salaries accrued from August 31, 2010 to September 30, 2012 .																			Pursuant to these agreements, the executives agreed to waive receipt of and release the Company from the payment of 50% of their salaries accrued from August 31, 2010 to September 30, 2012 .
Employee Compensation Amount Of Waiver																																																																																					66,083						56,250		43,333
Shares Issued In Consideration For Waiver																																																																																					66,083						56,250		43,333
Employee Compensation Payment Terms									Any remaining accrued salary remains outstanding and shall be paid (i) from time to time at the discretion of the Board of Directors to the extent the Board of Directors determines that such payment will not jeopardize the ability of the Company to continue as a going concern; or (ii) upon the closing of any single financing transaction (including a single financing transaction that contemplates multiple closings) in which the Company receives proceeds of $5 million or more.																Any remaining accrued salary remains outstanding and shall be paid (i) from time to time at the discretion of the Board of Directors to the extent the Board of Directors determines that such payment will not jeopardize the ability of the Company to continue as a going concern; or (ii) upon the closing of any single financing transaction (including a single financing transaction that contemplates multiple closings) in which the Company receives proceeds of $5 million or more.
Single Financing Transaction Minimum Proceeds									5,000,000																5,000,000
Indemnity Conversion Price Per Share Maximum Limit									$ 0.04718																$ 0.04718																		$ 0.04718
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	305,000													305,000												5,500,000						15,000,000				305,000													333,334				5,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross																																																																																						1,400,000						1,200,000		920,000		250,000	25,000
Weighted Average Exercise Price, Granted				$ 0.06	$ 0.04718																											$ 0.25																																															$ 16.50								$ 0.04718									$ 0.04718	$ 0.04718	$ 0.04718
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period																																36 months																																																							36 months									36 months		48 months
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights																																																																																						12.50						12.50		12.50
Volume Of Shares Traded On Open Market			283,400					36,700	15,000
Trading Days									48 days																																				22 days	21 days	11 days			58 days	50 days	48 days
Per Share Value Of Shares Traded On Open Market									$ 0.83																																				$ 0.46	$ 0.49	$ 0.76			$ 0.83	$ 2.50	$ 0.83
Convertible Notes Payable		2,000,000		2,000,000					2,000,000					2,000,000																																																																																			3,023,900
Debt Instrument, Convertible, Conversion Price																																					$ 9.00																														$ 1	$ 3					$ 0.04718										$ 0.04718
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value									$ 0.04718
Warants Exercise Price																																																																		$ 3.00			$ 3.00
Warants Exercise Price As Adjusted																																																																		$ 1.00			$ 1.00
Warrants To Purchase Common Stock						30,000			67,170	5,000	8,334	3,334																					126,949	30,000													166,668	85,282				83,334												127,173						296,735																									6,667				446,675					8,334
Stock issued for purchase of common stock (in shares)																																										2,780,000																																						2,780,000	450,000	400,000		50,000
Common Stock Issue Price Per Share																							$ 0.25																																																									$ 0.25
Proceeds from Issuance of Private Placement																							2,500,000																																																			695,000						695,000	695,000	100,000		12,500
Number Of Accredited Investors																																																																																17
Preferred Stock, Par or Stated Value Per Share																																												$ 0.001
Proceeds from Convertible Debt																																																																									$ 2,000,000
Number Of Warrants Surrendered									2,823
Warrants Outstanding		1,193,556		1,193,556	547,095				1,193,556					2,164,440			980,390